Tango Therapeutics Target Price

See Tango Therapeutics's analyst price targets ($44) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$22.52

Average Target Price

$44.40

97.2% upside

15 analysts in the last 4 months

High: $69 | Low: $24

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-18	H.C. WainwrightRobert Burns	$68	202% upside
2026-08-12	Guggenheim	$35	55.4% upside
2026-07-17	Mizuho Securities	$40	77.6% upside
2026-06-29	Canaccord Genuity	$46	104.3% upside
2026-06-25	Jefferies	$60	166.4% upside
2026-06-09	H.C. Wainwright	$66	193.1% upside
2026-06-09	Canaccord Genuity	$42	86.5% upside
2026-06-08	Leerink Partners	$69	206.4% upside
2026-06-08	Mizuho SecuritiesJoseph Catanzaro	$36	59.9% upside
2026-06-08	Wolfe Research	$35	55.4% upside
2026-05-15	Mizuho SecuritiesJoseph Catanzaro	$30	33.2% upside
2026-05-14	Piper Sandler	$24	6.6% upside
2026-05-14	UBS	$55	144.2% upside
2026-05-14	Wedbush	$33	46.5% upside
2026-05-14	JefferiesMaury Raycroft	$27	19.9% upside
2026-04-27	Stifel Nicolaus	$40	77.6% upside
2026-03-09	Stifel NicolausLaura Prendergast	$24	6.6% upside
2026-03-05	JefferiesMaury Raycroft	$18	20.1% downside
2026-02-23	Mizuho Securities	$19	15.6% downside
2026-01-16	Piper Sandler	$14	37.8% downside
2025-12-03	Stifel Nicolaus	$15	33.4% downside
2025-10-24	GuggenheimMichael Schmidt	$12	46.7% downside
2024-09-17	Piper SandlerJoseph Catanzaro	$18	20.1% downside
2024-08-08	WedbushRobert Driscoll	$13	42.3% downside
2024-05-28	H.C. WainwrightRobert Burns	$13	42.3% downside

Tango Therapeutics (TNGX) FAQ

The latest target price for TNGX is $44. Investors often review this figure alongside Tango Therapeutics's historical trend and sector peers before judging valuation or financial health.

Tango Therapeutics trades near $22.52 while the consensus target sits at $44 (97.2% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting TNGX's target price ($44), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Tango Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.